Cellular utake of the Tat peptide: An endocytosis mechanism following ionic interactions

Journal of Molecular Recognition

Volumn 16, Issue 5, 2003, Pages 265-271

  Vives, Eric ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Cell uptake; Cell penetrating peptide; Fixation; Tat peptide

Indexed keywords

ADENOVIRIDAE;

MEMBRANE PROTEIN; PEPTIDE; TRANSACTIVATOR PROTEIN;

ACTIVE TRANSPORT; ANIMAL; ENDOCYTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; ENDOCYTOSIS; GENE PRODUCTS, TAT; HIV-1; HUMANS; MEMBRANE PROTEINS; PEPTIDES;

EID: 0141907727     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.636     Document Type: Conference Paper

References (50)

1. Alblas J, Ulfman L, Hordijk P, Koenderman L. 2001. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol. Biol. Cell 12(7): 2137-2145.
2. Anderson RG, Kamen BA, Rothberg KG, Lacey SW. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255(5043): 410-411.
3. Anderson DC, Nichols E, Manger R, Woodle D, Barry M, Fritzberg AR. 1993. Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide. Biochem. Biophys. Res. Commun. 194(2): 876-884.
4. Astriab-Fisher A, Sergueev DS, Fisher M, Shaw BR, Juliano RL. 2000. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem. Pharmac. 60(1): 83-90.
5. Astriab-Fisher A, Sergueev D, Fisher M, Shaw BR, Juliano RL. 2002. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19(6): 744-754.
6. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. 2001. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50(1): 77-82.
7. Derossi D, Joliot AH, Chassaing G, Prochiantz A. 1994. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269(14): 10444-10450.
8. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. 1996. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271(30): 18188-18193.
9. Derossi D, Chassaing G, Prochiantz A. 1998. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8(2): 84-87.
10. Diaz-Griffero F, Hoschander SA, Brojatsch J. 2002. Endocytosis is a critical step in entry of subgroup B avian leukosis viruses. J. Virol. 76(24): 12866-12876.
11. Dostmann WR, Taylor MS, Nickl CK, Brayden JE, Frank R, Tegge WJ. 2000. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase 1alpha inhibit NO-induced cerebral dilation. Proc. Natl Acad. Sci. USA 97(26): 14772-14777.
12. Drin G, Demene H, Temsamani J, Brasseur R. 2001. Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. Biochemistry 40(6): 1824-1834.
13. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M, Nakanishi M. 2001. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276(28): 26204-26210.
14. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA 91(2): 664-668.
15. Futaki S. 2002. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 245(1-2): 1-7.
16. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. 2001. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276(8): 5836-5840.
17. Futaki S, Nakase I, Suzuki T, Youjun Z, Sugiura Y. 2002. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41(25): 7925-7930.
18. Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Hickey R, Giordano FJ, Sessa WC. 2003. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat. Med. 9(3): 357-363.
19. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, Ruley HE. 2001. Epigenetic regulation of gene structure and function with a cell- permeable Cre recombinase. Nat. Biotechnol. 19(10): 929-933.
20. Kramer SD, Wunderli-Allenspach H. 2003. No entry for Tat(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation oc cell-penetrating peptides. Biochem. Biophys. Acta 1609: 161-169.
21. Kwon HY, Eum WS, Jang HW, Kang JH, Ryu J, Ryong Lee B, Jin LH, Park J, Choi SY. 2000. Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett. 485(2-3): 163-167.
22. Leifert JA, Harkins S, Whitton JL. 2002. Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther. 9(21): 1422-1428.
23. Leonetti JP, Degols G, Lebleu B. 1990. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjug. Chem. 1(2): 149-153.
24. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. 2000. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18(4): 410-414.
25. Lindsay MA. 2002. Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmac. 2(5): 587-594.
26. Lundberg M, Johansson M. 2002. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291(2): 367-371.
27. Mann DA, Frankel AD. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. Embo J. 10(7): 1733-1739.
28. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. 2000. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56(5): 318-325.
29. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. 1998. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4(12): 1449-1452.
30. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F. 2002. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl Acad. Sci. USA 99(7): 4489-4494.
31. Pichon C, Monsigny M, Roche AC. 1999. Intracellular localization of oligonucleotides: influence of fixative protocols. Anti-sense Nucl. Acid Drug Dev. 9(1): 89-93.
32. Prochiantz A. 1996. Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol. 6(5): 629-634.
33. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. 2003. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278(1): 585-590.
34. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL, Wender PA. 2002. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45(17): 3612-3618.
35. Rusnati M, Tulipano G, Urbinati C, Tanghetti E, Giuliani R, Giacca M, Ciomei M, Corallini A, Presta M. 1998. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparinmimicking extracellular Tat antagonists. J. Biol. Chem. 273(26): 16027-16037.
36. Sazani P, Gemignani F, Kang SH, Maier MA, Manoharan M, Persmark M, Bortner D, Kole R. 2002. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20(12): 1228-1233.
37. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. 1999. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285(5433): 1569-1572.
38. Silhol M, Tyagi M, Giacca M, Lebleu B, Vives E. 2002. Different mechanisms for cellular internalization of the HIV-1 Tatderived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269(2): 494-501.
39. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y. 2002. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277(4): 2437-2443.
40. Thilo L, Stroud E, Haylett T. 1995. Maturation of early endosomes and vesicular traffic to lysosomes in relation to membrane recycling. J. Cell Sci. 108: 1791-1803.
41. Thoren PE, Persson D, Karlsson M, Norden B. 2000. The antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation. FEBS Lett. 482(3): 265-268.
42. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. 2001. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl Acad. Sci. USA 98(15): 8786-8791.
43. Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, D'Souza GG. 2003. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl Acad. Sci. USA 100(4): 1972-1977.
44. Tyagi M, Rusnati M, Presta M, Giacca M. 2001. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276(5): 3254-3261.
45. Umezawa N, Gelman MA, Haigis MC, Raines RT, Gellman SH. 2002. Translocation of a beta-peptide across cell membranes. J. Am. Chem. Soc. 124: 368-369.
46. Varki NM, Reisfeld RA, Walker LE. 1984. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res. 44(2): 681-687.
47. Vives E, Brodin P, Lebleu B. 1997a. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272(25): 16010-16017.
48. Vives E, Granier C, Prevot P, Lebleu B. 1997b. Structure activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein. Lett. Peptide Sci. 4: 429-436.
49. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB. 2000. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97(24): 13003-13008.
50. Zelphati O, Szoka FJ. 1996. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl Acad. Sci. USA 93(21): 11493-11498.